The company plans to utilise the net proceeds from the fresh issue towards funding capital expenditure for setting up a new pharmaceutical manufacturing facility on its existing land.
The company plans to utilise the net proceeds from the fresh issue towards funding capital expenditure for setting up a new pharmaceutical manufacturing facility on its existing land.
<iframe src="https://hindustansphere.com/embed/cluster/06358f283654895f4eba28ad5dafddd3523c5f82" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Claroid Pharma Files IPO Draft Papers To Offer 1.26 Crore Shares: Here Are The Key Risk Factors"></iframe>
